If companies couldn't recover their cost? That should be a fairly simple question to answer.
The U.S. Congress shall have power to promote the progress of science and useful arts by securing, for limited times, to...
90 percent of the prescriptions that are written and filled in the United States, roughly, are for generic drugs.
That is 20 years from when the invention occurs, and like you said sometimes you are only left with a few years to try a...
So the copay, because of the way the pharmacy benefit managers work and the other intermediaries, the copay that my cons...
It feels like to me, just in closing, we need some kind of truth in pricing here.
Biopharmaceutical companies are far outspending the Federal Government for R&D for cures for various diseases.
We don't need to have cures that could potentially come in the market not coming to the market.
This is according to the CBO, and they confirmed that there would be a loss of cures available on the market.
Policies that incentivize investment in pharmaceutical innovation is a good thing, and that is where we need to be focus...
We just simply cannot go down that path of eliminating any potential cure for some of these serious diseases.